Global Ganja Report

After the first day of Senate confirmation hearings for Jeff Sessions, president-elect Trump's choice to lead the US Justice Department, cannabis advocates are parsing his testimony for clues as to what the incoming administration's stance will be on whether to continue to give breathing room to state-level legalization and medical marijuana laws. The Los Angeles Times takes an ominous view, writing in a headline: "Sessions leaves door open to reviving federal war on pot."

Is the alcohol industry spending money to get members of Congress to pay attention to the problem of "marijuana-impaired driving"? That's the case made on the cannabis industry website Marijuana.com, where a blogger seems to have assiduously searched the famous WikiLeaks dump of DNC e-mails for any reference to our favorite herb. What they found was in the May 24, 2016 edition of Huddle, a daily e-newsletter for Capitol Hill insiders produced by the Politico website. That issue included a paid advertisement from the Wine & Spirits Wholesalers of America (WSWA), which read in part:

To little fanfare, President Barack Obama on May 16 signed into law the Transnational Drug Trafficking Act—further extending the global reach of US narcotics enforcement. The law criminalizes manufacture of drugs anywhere in the world if the producers "intend, know, or have probable cause to believe" the substances will be illegally imported into the United States. The language has been attacked as overbroad, potentially applying to any link of the production chain—down to lowly peasant growers of cannabis, coca leaf or opium.

On Dec. 18, Congress approved a $1.1 trillion dollar spending bill—and in the process approved a provision promising to keep federal law enforcement out of medical marijuana operations in states that have passed acts legalizing them. The provision, known as the Rohrabacher-Farr amendment, was first approved in December of last year. The rider for a second year bars the use of Department of Justice funds "to prevent such States from implementing their own State laws that authorize the use, distribution, possession, or cultivation of medical marijuana."

Legislators on Capitol Hill passed three amendments June 3 to bar the DEA and Department of Justice from undermining state marijuana laws, as part of the US House of Representatives' consideration of the Fiscal Year 2016 Commerce, Justice, and Science Appropriations bill. "There’s unprecedented support on both sides of the aisle for ending the federal war on marijuana and letting states set their own drug policies based on science, compassion, health, and human rights," said Bill Piper, director of national affairs for the Drug Policy Alliance. "The more the DEA blocks sensible reforms the more they will see their agency's power and budget come under deeper scrutiny."

A bipartisan group of US Senators on March 10 announced legislation to end the federal ban on medical marijuana. The Compassionate Access, Research Expansion and Respect States (CARERS) Act is sponsored by senators Kirsten Gillibrand (D-NY) Rand Paul (R-KY) and Cory Booker (D-NJ). If passed, the bill would end the federal restriction on medical marijuana and allow for several comprehensive reforms, including: permission for limited interstate transport, an expansion of access to cannabis for research purposes, and reclassification of marijuana from Schedule I to II. Medical marijuana, and the right of states to determine how to regulate it, has found bipartisan support in both the House and Senate. (Jurist, March 10)

The House and Senate appropriations leadership has hammered out a budget bill that includes an historic amendment to curb federal Department of Justice (DoJ) enforcement in medical marijuana states. The measure, which was originally passed by the House in May with a 219-189 vote, aims to prohibit the DoJ from spending taxpayer money to undermine state medical marijuana laws. "This is great news for medical marijuana patients all across the country," said Rep. Sam Farr (D-CA), one of the co-authors of the House measure. "This amendment protects patients while the federal government catches up with the views of the American people. Patients will have access to the care legal in their state without fear of federal prosecution. And our federal dollars will be spent more wisely on fighting actual crimes and not wasted going after patients."

US representatives Earl Blumenauer (D-OR) and Dana Rohrabacher (R-CA), along with ten bipartisan co-sponsors introduced, the Veterans Equal Access Act (VEAA) Nov. 20, to allow our country's veterans to become medical marijuana patients in states where it's legal. The VEAA would allow Veterans Affairs (VA) physicians to recommend medical marijuana to their patients, a right enjoyed by physicians outside of the VA system. "Post traumatic stress and traumatic brain injury are just as damaging and harmful as any injuries that are visible from the outside," said Blumenauer, the bill's author. "Sometimes even more so because of the devastating effect they can have on a veteran's family. We should be allowing these wounded warriors access to the medicine that will help them survive and thrive, including medical marijuana, not treating them like criminals and forcing them into the shadows. It's shameful."